tiprankstipranks
Trending News
More News >
Hightide Therapeutics Inc (HK:2511)
:2511
Hong Kong Market
Advertisement

Hightide Therapeutics Inc (2511) Price & Analysis

Compare
0 Followers

2511 Stock Chart & Stats


Financials

2511 FAQ

What was Hightide Therapeutics Inc’s price range in the past 12 months?
Hightide Therapeutics Inc lowest stock price was HK$0.72 and its highest was HK$3.90 in the past 12 months.
    What is Hightide Therapeutics Inc’s market cap?
    Hightide Therapeutics Inc’s market cap is HK$2.01B.
      When is Hightide Therapeutics Inc’s upcoming earnings report date?
      Hightide Therapeutics Inc’s upcoming earnings report date is Mar 28, 2025 which is 111 days ago.
        How were Hightide Therapeutics Inc’s earnings last quarter?
        Currently, no data Available
        Is Hightide Therapeutics Inc overvalued?
        According to Wall Street analysts Hightide Therapeutics Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Hightide Therapeutics Inc pay dividends?
          Hightide Therapeutics Inc does not currently pay dividends.
          What is Hightide Therapeutics Inc’s EPS estimate?
          Hightide Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Hightide Therapeutics Inc have?
          Hightide Therapeutics Inc has 571,325,700 shares outstanding.
            What happened to Hightide Therapeutics Inc’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Hightide Therapeutics Inc?
            Currently, no hedge funds are holding shares in HK:2511

            Hightide Therapeutics Inc Stock Smart Score

            9
            Outperform
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10

            Technicals

            SMA
            Positive
            20 days / 200 days
            Momentum
            177.60%
            12-Months-Change

            Fundamentals

            Return on Equity
            -67.57%
            Trailing 12-Months
            Asset Growth
            -31.93%
            Trailing 12-Months

            Company Description

            Hightide Therapeutics Inc

            Hightide Therapeutics Inc (2511) is a biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of metabolic and digestive diseases. The company leverages its expertise in drug development to address unmet medical needs and improve patient outcomes. Hightide Therapeutics is committed to advancing its pipeline of proprietary compounds and fostering collaborations to bring novel treatments to market.
            Similar Stocks
            Company
            Price & Change
            Follow
            Viva Biotech Holdings
            Sino Biopharmaceutical
            Shanghai Fosun Pharmaceutical (Group) Co
            Wuxi Biologics (Cayman)
            CSPC Pharmaceutical Group
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis